Type I procollagen

Type I procollagen is the immediate precursor to mature type I collagen, synthesized as a triple-helical protein consisting of two pro-alpha1(I) chains (encoded by COL1A1) and one pro-alpha2(I) chain (encoded by COL1A2)[1][2][3]. The synthesis of type I procollagen involves gene transcription, translation, extensive post-translational modifications (including hydroxylation and glycosylation), followed by secretion and enzymatic cleavage of propeptide ends to yield mature collagen, which is then assembled into strong fibrils throughout connective tissues, bones, skin, tendons, and organs[3][5]. Disorders of procollagen synthesis result in pathologies such as osteogenesis imperfecta and Ehlers-Danlos syndrome; biochemical markers derived from cleavage fragments (PINP and PICP) are widely used in clinical monitoring of bone turnover and fibrosis[4][5]. The process is tightly regulated and affected by various genetic and nutritional factors (e.g., vitamin C dependent enzymes)[5]. In summary, "Type I procollagen synthesis" is not a canonical molecule/receptor target, but denotes a process involved in the biosynthesis of type I collagen; it should be mapped either to "Type I procollagen" (the protein precursor) or to the biosynthetic pathway itself, not used as a target name.

Other names

Type I collagen precursorpro-alpha1(I) chainpro-alpha2(I) chainPINP (Procollagen type I N-terminal propeptide)PICP (Procollagen type I C-terminal propeptide)

Inhibition or modulation of collagen synthesis (e.g., via inhibition of growth factors or downstream enzymes)